Press release
Marginal Zone Lymphoma Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC
DelveInsight's "Marginal Zone Lymphoma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Marginal Zone Lymphoma, historical and forecasted epidemiology as well as the Marginal Zone Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Marginal Zone Lymphoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Marginal Zone Lymphoma Market Forecast [https://www.delveinsight.com/sample-request/marginal-zone-lymphoma-market?utm_source=abnewsire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Marginal Zone Lymphoma Market Report:
*
The Marginal Zone Lymphoma market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In August 2024, The UK National Institute for Health and Care Excellence (NICE) has endorsed BeiGene's Zanubrutinib (Brukinsa) for treating marginal zone lymphoma (MZL), a form of blood cancer, within the National Health Service (NHS). This approval introduces a new treatment option for patients in England, with the potential to slow cancer progression and reduce the need for additional chemotherapy.
*
In 2023, the United States recorded the highest number of marginal zone lymphoma (MZL) incidence cases among the 7MM, exceeding 8,000 cases. This number is projected to grow throughout the forecast period.
*
In gender-specific Marginal Zone Lymphoma incidence cases, males represent the predominant group.
*
In 2023, MALT lymphoma accounted for the largest proportion of incident cases in the US, comprising approximately 70%, followed by SMZL and NMZL.
*
In the US in 2023, stage-specific incidence of Marginal Zone Lymphoma was highest for Stage III-IV cases, followed by Stage I and Stage II.
*
YESCARTA and BREYANZI are gaining recognition as promising treatments for MZL, with BREYANZI anticipated to receive approval for third-line (3L+) MZL cases by 2026.
*
Key Marginal Zone Lymphoma Companies: Bristol-Myers Squibb, TG Therapeutics, Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma, Beigene, Incyte Corporation, Enterome, and others
*
Key Marginal Zone Lymphoma Therapies: REVLIMID (lenalidomide), UKONIQ (umbralisib), BREYANZI (lisocabtagene maraleucel), Yescarta, Calquence, Betalutin, Obinutuzumab, Rituximab, Ibrutinib, HMPL-689, Zanubrutinib, tafasitamab, EO2463, and others
*
The Marginal Zone Lymphoma epidemiology based on gender analyzed that a higher number of males were affected by this disease, i.e., ~54%of the total incident MZL population in the United States, which is equivalent to ~4,300 cases. In comparison to this, for females, the number of cases observed was ~3,700 in 2022.
*
The Marginal Zone Lymphoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Marginal Zone Lymphoma pipeline products will significantly revolutionize the Marginal Zone Lymphoma market dynamics.
Marginal Zone Lymphoma Overview
Marginal Zone Lymphoma (MZL) is a type of non-Hodgkin lymphoma, a cancer that originates in white blood cells called lymphocytes. MZL specifically affects a subset of these lymphocytes known as marginal zone B-cells, which are found at the edges, or margins, of lymphoid tissues like the lymph nodes, spleen, and mucosa-associated lymphoid tissue (MALT) such as the stomach, salivary glands, or other organs.
Get a Free sample for the Marginal Zone Lymphoma Market Forecast, Size & Share Analysis Report:
http://delveinsight.com/report-store/marginal-zone-lymphoma-market [http://delveinsight.com/report-store/marginal-zone-lymphoma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Marginal Zone Lymphoma Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Marginal Zone Lymphoma Epidemiology Segmentation:
The Marginal Zone Lymphoma market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Marginal Zone Lymphoma
*
Prevalent Cases of Marginal Zone Lymphoma by severity
*
Gender-specific Prevalence of Marginal Zone Lymphoma
*
Diagnosed Cases of Episodic and Chronic Marginal Zone Lymphoma
Download the report to understand which factors are driving Marginal Zone Lymphoma epidemiology trends @ Marginal Zone Lymphoma Epidemiology Forecast [https://www.delveinsight.com/sample-request/marginal-zone-lymphoma-market?utm_source=abnewsire&utm_medium=pressrelease&utm_campaign=gpr]
Marginal Zone Lymphoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Marginal Zone Lymphoma market or expected to get launched during the study period. The analysis covers Marginal Zone Lymphoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Marginal Zone Lymphoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Marginal Zone Lymphoma Therapies and Key Companies
*
REVLIMID (lenalidomide): Bristol-Myers Squibb
*
UKONIQ (umbralisib): TG Therapeutics
*
BREYANZI (lisocabtagene maraleucel): Bristol Myers Squibb
*
Yescarta: Gilead Sciences
*
Calquence: AstraZeneca
*
Betalutin: Nordic Nanovector
*
Obinutuzumab: Christian Buske
*
Rituximab: AbbVie
*
Ibrutinib: Pharmacyclics LLC
*
HMPL-689: Hutchison Medipharma
*
Zanubrutinib: Beigene
*
tafasitamab: Incyte Corporation
*
EO2463: Enterome
Discover more about therapies set to grab major Marginal Zone Lymphoma market share @ Marginal Zone Lymphoma Treatment Landscape [https://www.delveinsight.com/sample-request/marginal-zone-lymphoma-market?utm_source=abnewsire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Marginal Zone Lymphoma Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Marginal Zone Lymphoma Companies: Bristol-Myers Squibb, TG Therapeutics, Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma, Beigene, Incyte Corporation, Enterome, and others
*
Key Marginal Zone Lymphoma Therapies: REVLIMID (lenalidomide), UKONIQ (umbralisib), BREYANZI (lisocabtagene maraleucel), Yescarta, Calquence, Betalutin, Obinutuzumab, Rituximab, Ibrutinib, HMPL-689, Zanubrutinib, tafasitamab, EO2463, and others
*
Marginal Zone Lymphoma Therapeutic Assessment: Marginal Zone Lymphoma current marketed and Marginal Zone Lymphoma emerging therapies
*
Marginal Zone Lymphoma Market Dynamics: Marginal Zone Lymphoma market drivers and Marginal Zone Lymphoma market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Marginal Zone Lymphoma Unmet Needs, KOL's views, Analyst's views, Marginal Zone Lymphoma Market Access and Reimbursement
To know more about Marginal Zone Lymphoma companies working in the treatment market, visit @ Marginal Zone Lymphoma Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/marginal-zone-lymphoma-market?utm_source=abnewsire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Marginal Zone Lymphoma Market Report Introduction
2. Executive Summary for Marginal Zone Lymphoma
3. SWOT analysis of Marginal Zone Lymphoma
4. Marginal Zone Lymphoma Patient Share (%) Overview at a Glance
5. Marginal Zone Lymphoma Market Overview at a Glance
6. Marginal Zone Lymphoma Disease Background and Overview
7. Marginal Zone Lymphoma Epidemiology and Patient Population
8. Country-Specific Patient Population of Marginal Zone Lymphoma
9. Marginal Zone Lymphoma Current Treatment and Medical Practices
10. Marginal Zone Lymphoma Unmet Needs
11. Marginal Zone Lymphoma Emerging Therapies
12. Marginal Zone Lymphoma Market Outlook
13. Country-Wise Marginal Zone Lymphoma Market Analysis (2020-2034)
14. Marginal Zone Lymphoma Market Access and Reimbursement of Therapies
15. Marginal Zone Lymphoma Market Drivers
16. Marginal Zone Lymphoma Market Barriers
17. Marginal Zone Lymphoma Appendix
18. Marginal Zone Lymphoma Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=marginal-zone-lymphoma-market-growth-to-accelerate-in-forecast-period-20232032-delveinsight-analyzes-gilead-sciences-astrazeneca-nordic-nanovector-christian-buske-abbvie-pharmacyclics-llc]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Marginal Zone Lymphoma Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC here
News-ID: 3752135 • Views: …
More Releases from ABNewswire
Eco Friendly Tablecloth Options for Restaurants and Catering Services
Okay, let's be real-running a restaurant or catering business isn't just about cooking great food anymore. People care about the planet now, and honestly, we should too. One thing that's super easy to change but makes a big impact? Your Tablecloth [https://www.sdjiayuantech.com/tablecloth/]s. Yep, switching to an eco friendly tablecloth option is a small move that really counts.
Why You'd Even Bother
Look, customers notice. If your place is making eco-friendly choices, people…
Peak Performance with Advanced Crawler Shot Blasting Machines
Crawler Shot Blasting Machines [https://www.xkmtmachinery.com/crawler-type-shot-blasting-machine/]
Core Function & Superior Advantages: Our Automatic Shot Blasting Machine [https://www.xkmtmachinery.com/shot-blasting-machine/] processes components placed on a continuous rubber crawler belt, tumbling them through a high-velocity blast stream. This ensures complete, uniform coverage for optimal rust, scale, and contaminant removal, creating the perfect profile for coatings.
Key advantages include: Process high volumes of small to medium-sized parts (castings, forgings, fasteners) rapidly. The tumbling action ensures all surfaces are…
New Batch of 3 Level Car Stackers in Production with Galvanized Surface for Dura …
We are pleased to announce that a new batch of 3 level Car Stacker [https://www.cncherish.com/car-stacker/]s https://www.cncherish.com/triple-car-stacker-four-post-car-parking-lifts/ is currently in production. These units are equipped with a reliable mechanical lock release system, providing safe and efficient parking solutions for a wide range of vehicles.
Each Parking Lift [https://www.cncherish.com/parking-lift-1/] is engineered to accommodate both sedans and SUVs, offering maximum flexibility for customers with diverse parking needs. To ensure long-lasting durability, the units feature…
Lyme Disease Pipeline 2025: In-depth Clinical Trials Analysis and Emerging Thera …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lyme Disease pipeline constitutes 7+ key companies continuously working towards developing 7+ Lyme Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Lyme Disease Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Lyme Disease Market.
The Lyme Disease Pipeline report…
More Releases for Marginal
Marginal-lubricating Bearings Market to Witness Robust Expansion by 2025
The latest research report"Global Marginal-lubricating Bearings Market Growth 2025-2031" studied by LP Information offers a comprehensive overview of theMarginal-lubricating Bearings market, providing insights into its drivers, restraints, and future trends. This study employs both primary and secondary research methods to offer unbiased perspectives on the globalMarginal-lubricating Bearings industry, assisting decision-makers in making informed business choices.
The research employs Porter's Five Forces analysis and SWOT analysis to offer a clear understanding…
Marginal Zone Lymphoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Marginal Zone Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Marginal Zone Lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Auto Injector Market In-Depth Analysis & Marginal Revenue Growth
An autoinjector (or auto-injector) is a medical device designed to deliver a dose of a particular drug. The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
Most autoinjectors are one-use, disposable, spring-loaded syringes. By design, autoinjectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded,…
Latest Trends in Marginal Zone Lymphoma Treatment Market 2020-2025
Market Overview
The Marginal Zone Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations during COVID-19 outbreak.
Market segmentation
Marginal Zone Lymphoma Treatment market is split by Type and Application. For…
A2P SMS Market Cost Profit and Marginal Revenue Analysis by 2026
In this Report Titled Global A2P SMS Market Growth (Status and Outlook) 2019-2026 the latest data has been delivered, along with collection of realistic information, quantitative and qualitative estimation by industry experts, and the contribution from industry associates across the value chain. This report is a vast research database spread across various pages with numerous tables, charts, and figures in it. This report presents a close watch on the dominating…
Baking Fats Market In-Depth Analysis & Marginal Revenue Growth 2020-2026
How will be investment trends and competition in the global Baking Fats market during forecast period 2020-2026? Get the detail insights from QY Research.
Los Angeles, United State, February 2020: The report is just the right resource that global and regional Baking Fats players and investors need to peep into the future of their business and plan out effective growth strategies. It is a compilation of intelligent and accurate research and…
